48 results
424B3
CYDY
CytoDyn Inc.
29 Jan 24
Prospectus supplement
5:22pm
in the Company’s Employee Handbook, Code of Ethics and Business Conduct, Statement of Insider Trading Policy and Related Trading Procedures, and other
8-K
EX-10.1
CYDY
CytoDyn Inc.
29 Jan 24
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
8:40am
of Ethics and Business Conduct, Statement of Insider Trading Policy and Related Trading Procedures, and other policies, memoranda and communications
424B3
CYDY
CytoDyn Inc.
22 Nov 23
Prospectus supplement
12:16pm
set forth in the Company’s Employee Handbook, Code of Ethics and Business Conduct, Statement of Insider Trading Policy and Related Trading Procedures
8-K
EX-10.1
CYDY
CytoDyn Inc.
21 Nov 23
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO
5:15pm
include, among other things and without limitation, terms and conditions set forth in the Company’s Employee Handbook, Code of Ethics and Business Conduct
424B3
rt3jdszed864864yu4b
24 Oct 23
Prospectus supplement
6:01am
424B3
vpnpw8a7pou dh
10 Oct 23
Prospectus supplement
6:02pm
POS AM
d8atm6 94qg7
2 Oct 23
Prospectus update (post-effective amendment)
5:15pm
424B3
6uh8527b2rje 7dhj8
11 Jul 23
Prospectus supplement
5:28pm
DEFC14A
27jayw1r0 tfqihyjbx
14 Oct 21
Proxy in contested solicitation
9:27am